Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022

Between December 2021 and June 2022, 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae (ST8123; n = 8) were detected in the United Kingdom, compared with nine cases during the previous 6 years. Most of these cases were associated with travel from the Asia-Pacific region; all were heterosexual people, with most in their 20s. Although all cases were successfully treated, not all partners of cases could be traced, and there is a risk of further transmission of ceftriaxone-resistant gonococcal infection within the UK.

[1]  M. Unemo,et al.  Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[2]  L. Sánchez-Busó,et al.  Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study. , 2022, The Lancet. Microbe.

[3]  T. Kesteman,et al.  Neisseria gonorrhoeae FC428 Subclone, Vietnam, 2019–2020 , 2022, Emerging infectious diseases.

[4]  Liying Sun,et al.  Typing of Neisseria gonorrhoeae Isolates in Shenzhen, China, from 2014 to 2018 Reveals the Shift of Genotypes Significantly Associated with Antimicrobial Resistance , 2021, Antimicrobial Agents and Chemotherapy.

[5]  Richard J. Goater,et al.  A community-driven resource for genomic epidemiology and 1 antimicrobial resistance prediction of Neisseria gonorrhoeae 2 at Pathogenwatch 3 4 , 2020 .

[6]  S. van der Veen,et al.  Sustained transmission of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China. , 2020, The Journal of antimicrobial chemotherapy.

[7]  K. Osawa,et al.  Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates. , 2019, The Journal of antimicrobial chemotherapy.

[8]  M. Unemo,et al.  Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16. , 2019, The Journal of antimicrobial chemotherapy.

[9]  J. Hocking,et al.  Kissing may be an important and neglected risk factor for oropharyngeal gonorrhoea: a cross-sectional study in men who have sex with men , 2019, Sexually Transmitted Infections.

[10]  T. Street,et al.  Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018 , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  M. Unemo,et al.  Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012–2017 , 2019, Emerging infectious diseases.

[12]  M. Unemo,et al.  Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  Raquel Abad,et al.  Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey , 2018, The Lancet. Infectious diseases.

[14]  M. Unemo,et al.  New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan , 2016, Antimicrobial Agents and Chemotherapy.

[15]  M. Unemo,et al.  Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates in Kyoto and Osaka, Japan, 2010 to 2012: Intensified Surveillance after Identification of the First Strain (H041) with High-Level Ceftriaxone Resistance , 2013, Antimicrobial Agents and Chemotherapy.

[16]  M. Unemo,et al.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. , 2012, Future microbiology.

[17]  Josefina Ayats,et al.  Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. , 2012, The Journal of antimicrobial chemotherapy.

[18]  M. Unemo,et al.  High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure , 2011, Antimicrobial Agents and Chemotherapy.

[19]  L. Ng,et al.  Mutation in 23S rRNA Associated with Macrolide Resistance in Neisseria gonorrhoeae , 2002, Antimicrobial Agents and Chemotherapy.